BriaCell completes 15:1 share consolidation to comply with Nasdaq listing

BriaCell Therapeutics Corp.

Consolidation effective Jan 24, 2025; post-consolidation shares begin trading Jan 29, 2025.
Shares reduced from 44,204,061 to 2,946,940; no fractional shares issued.
New CUSIP: 107930208; tickers BCTX and BCTXW unchanged on Nasdaq and TSX.
Exercise prices and conversion ratios on convertible securities proportionately adjusted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.